Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of TNF-alpha Inhibition in Sciatica With Post-operative Lumbar Spinal Fibrosis
NCT00385086Phase 3Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Feb 2007
- Primary completion
- Oct 2012
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of infliximab in Sciatica (2 arms), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: Sciatica pain on Visual Analog Scale at 10 days. Started Feb 2007; status: completed.
02
Drugs
infliximab
03
Conditions
Sciatica
Beyond the preview
Go deeper on NCT00385086.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00385086.